Molecular determinants for cellular uptake of Tat protein of human immunodeficiency virus type 1 in brain cells.
about
Chemokine and chemokine-receptor expression in human glial elements: induction by the HIV protein, Tat, and chemokine autoregulationPACAP27 is protective against tat-induced neurotoxicityEstrogen protects against the synergistic toxicity by HIV proteins, methamphetamine and cocaineGonadal steroids differentially modulate neurotoxicity of HIV and cocaine: testosterone and ICI 182,780 sensitive mechanismInteraction between Tat and Drugs of Abuse during HIV-1 Infection and Central Nervous System DiseaseApolipoprotein E genotype and hepatitis C, HIV and herpes simplex disease risk: a literature reviewMechanisms of HIV-1 Tat neurotoxicity via CDK5 translocation and hyper-activation: role in HIV-associated neurocognitive disordersApoptotic death of striatal neurons induced by human immunodeficiency virus-1 Tat and gp120: Differential involvement of caspase-3 and endonuclease GSynergistic neurotoxicity of opioids and human immunodeficiency virus-1 Tat protein in striatal neurons in vitroNeonatal intrahippocampal HIV-1 protein Tat(1-86) injection: neurobehavioral alterations in the absence of increased inflammatory cytokine activation.Neonatal intrahippocampal injection of the HIV-1 proteins gp120 and Tat: differential effects on behavior and the relationship to stereological hippocampal measuresHIV-1 Tat-induced changes in synaptically-driven network activity adapt during prolonged exposure.STAT3 and its phosphorylation are involved in HIV-1 Tat-induced transactivation of glial fibrillary acidic proteinTime-Dependent, HIV-Tat-Induced Perturbation of Human Neurons In Vitro: Towards a Model for the Molecular Pathology of HIV-Associated Neurocognitive DisordersHigh-performance capillary electrophoresis for determining HIV-1 Tat protein in neurons.Modifications in host cell cytoskeleton structure and function mediated by intracellular HIV-1 Tat protein are greatly dependent on the second coding exonIntact lipid rafts regulate HIV-1 Tat protein-induced activation of the Rho signaling and upregulation of P-glycoprotein in brain endothelial cellsPlatelet-derived growth factor CC-mediated neuroprotection against HIV Tat involves TRPC-mediated inactivation of GSK 3beta.Transient hypercapnia reveals an underlying cerebrovascular pathology in a murine model for HIV-1 associated neuroinflammation: role of NO-cGMP signaling and normalization by inhibition of cyclic nucleotide phosphodiesterase-5Excess soluble CD40L contributes to blood brain barrier permeability in vivo: implications for HIV-associated neurocognitive disordersCaffeine Blocks HIV-1 Tat-Induced Amyloid Beta Production and Tau Phosphorylation.HIV-1 Tat and opiate-induced changes in astrocytes promote chemotaxis of microglia through the expression of MCP-1 and alternative chemokines.Preferential vulnerability of astroglia and glial precursors to combined opioid and HIV-1 Tat exposure in vitro.Glial-restricted precursors: patterns of expression of opioid receptors and relationship to human immunodeficiency virus-1 Tat and morphine susceptibility in vitro.HIV-1 Tat-mediated induction of platelet-derived growth factor in astrocytes: role of early growth response gene 1HIV-1 Tat interacts with and regulates the localization and processing of amyloid precursor protein.Neurodegenerative effects of recombinant HIV-1 Tat(1-86) are associated with inhibition of microtubule formation and oxidative stress-related reductions in microtubule-associated protein-2(a,b)HIV-1 tat protein induces a migratory phenotype in human fetal microglia by a CCL2 (MCP-1)-dependent mechanism: possible role in NeuroAIDSCreatine protects against mitochondrial dysfunction associated with HIV-1 Tat-induced neuronal injury.Didehydro-cortistatin A inhibits HIV-1 Tat mediated neuroinflammation and prevents potentiation of cocaine reward in Tat transgenic miceHIV-1 Tat protein promotes neuronal dysfunction through disruption of microRNAs.Transduction of Cu, Zn-superoxide dismutase mediated by an HIV-1 Tat protein basic domain into human chondrocytes.Morphine potentiates neurodegenerative effects of HIV-1 Tat through actions at μ-opioid receptor-expressing glia.The presence of Epstein-Barr virus significantly impacts the transcriptional profile in immunodeficiency-associated Burkitt lymphoma.A monoclonal antibody directed against a conformational epitope of the HIV-1 trans-activator (Tat) protein neutralizes cross-cladeMolecular mechanisms in the dramatic enhancement of HIV-1 Tat transduction by cationic liposomes.Human immunodeficiency virus type-1 protein Tat induces tumor necrosis factor-alpha-mediated neurotoxicity.Differences in NMDA receptor expression during human development determine the response of neurons to HIV-tat-mediated neurotoxicityHuman immunodeficiency virus type 1 (HIV-1) transactivator of transcription through its intact core and cysteine-rich domains inhibits Wnt/β-catenin signaling in astrocytes: relevance to HIV neuropathogenesisHIV immune complexes prevent excitotoxicity by interaction with NMDA receptors.
P2860
Q22253485-5083DA7B-C373-46EC-A04A-B51F2B8FEE1DQ24293525-B0314CDB-67DB-4618-B749-F62E6B6A26D6Q24796371-176272C4-748C-4E9D-84FE-CE4C75A2C146Q24813383-1563751E-EDA9-4945-A0B2-5F4F5EE92EFBQ26770397-78E2B4A7-638C-49D6-8495-5D337B6F7FEEQ27491003-F534F73E-A899-465A-8282-BD33C688AD2EQ28082139-57D430A9-FE06-47D4-8401-0B3D529C4859Q28267535-B845C93D-6D7B-45F7-891E-3A80D5417259Q28354326-FB0DBDC2-3B2F-4958-9E5A-C005C7CF872CQ30399828-C1517B7F-E7C5-47DD-8FAC-8CAE77011DE4Q30486458-C3858D20-CD0D-4BA1-8255-1ADC016B2891Q30638542-AA1FDFE2-FD30-4366-9A4D-599846D41EA5Q33675464-56B522E1-EDC0-4127-B88D-1754BD0F9E60Q33734695-9921C38E-081A-4217-A24E-BC928E856BF3Q33797753-D3568EB0-A889-43D2-A471-7F405DCB4A49Q33889326-2523B4CE-91F4-4F09-891F-3B3E15366151Q34170914-9395E927-578B-4332-94DD-386D5F180996Q34450960-9E69FC06-4D84-4137-8E37-98AEFA726C4AQ34483568-97B49154-FE4C-4D14-90FE-E57C79D40837Q34517239-A668DB99-B98D-46DE-9226-07CB73E48D45Q34540333-87652719-51B7-4351-913F-4D6ABBFD78C8Q34797566-BD899541-7315-48C9-9D78-BC0F086C1B50Q35009483-5471974E-29A8-4032-953E-D87BE88753B2Q35019404-DCAE60E1-0CA2-4D3E-8EE2-2B450AA87793Q35031037-4AD22420-412A-4C89-80A4-1D05793C4108Q35060145-734EBB87-15CD-4E4D-B74D-9A0C6A1E0544Q35131200-CD65EAFA-8A70-40AE-A5B5-2D7DF056644CQ35150753-EB622F5D-3EE3-42A6-A2B8-0B5D8FE7A19DQ35215063-171E173E-C475-4506-A660-B29A2B60D46BQ35559749-BF178223-B4A2-46BE-B1CC-672BADED4EDAQ35562611-A6355B0A-89F0-46F7-8B74-F38C4EFBE3A4Q35605595-79BDF6D9-ED66-4163-8A82-FE282664E2C7Q35606725-192D4B63-E92A-4C70-88B0-4630939ADBECQ35711180-ADC6F639-0C1C-49E0-B11A-8C4C95EE7E4FQ35874415-B4F69590-E1BA-4EA9-8B5F-3EFCF832E47CQ36055526-F7E1412F-8190-4CD8-872A-B649893B2B5BQ36148402-7726EBA6-875F-4F2E-A9C0-062B5137A07DQ36296748-0EC33C7D-8C52-4378-8585-1F59809976F4Q36430096-DECDAE9C-A6F2-4D1E-BBCD-010EDCD02D43Q36565817-300BB3C7-AAA2-425E-9322-94160755793C
P2860
Molecular determinants for cellular uptake of Tat protein of human immunodeficiency virus type 1 in brain cells.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Molecular determinants for cel ...... y virus type 1 in brain cells.
@ast
Molecular determinants for cel ...... y virus type 1 in brain cells.
@en
type
label
Molecular determinants for cel ...... y virus type 1 in brain cells.
@ast
Molecular determinants for cel ...... y virus type 1 in brain cells.
@en
prefLabel
Molecular determinants for cel ...... y virus type 1 in brain cells.
@ast
Molecular determinants for cel ...... y virus type 1 in brain cells.
@en
P2860
P1433
P1476
Molecular determinants for cel ...... cy virus type 1 in brain cells
@en
P2860
P304
P407
P577
1997-03-01T00:00:00Z